Table 2 HIV associated clinical and laboratory characteristics of study participants
Variable | Mean (SD)/Median (IQR)/n (%) |
|---|---|
Duration of HIV diagnosis (years) | |
Median | 2 (2,3) |
< 2 | 83 (18.8) |
2–5 | 172 (39.1) |
> 5 | 185 (42.1) |
HIV type | |
1 | 432 (98.1) |
1 & 2 | 8 (1.8) |
Last WHO clinical stage before initiating ART | |
1 | 21 (4.7) |
2 | 101 (23.0) |
3 | 249 (56.6) |
4 | 69 (15.7) |
History of tuberculosis since HIV diagnosis | |
Yes | 13 (2.9) |
No | 427 (97.1) |
Duration on ART (years) | |
< 1 | 82 (18.6) |
1–2 | 69 (15.7) |
> 2 | 289 (65.7) |
ART regimen | |
First line regimen | 410 (93.2) |
Second line regimen | 30 (6.8) |
CD4 count cells/mm3 | |
Baseline Mean (N = 414) | 215.1 (±152.6) |
Mean after 6 months on ART (N = 376) | 386.6 (±178.5) |
Current Mean (N = 396) | 579.6 (±203.0) |
Plasma viral load after 6 months on ART, copies/ml(N = 317) | |
Median | 1080 (198, 2598) |
0 | 2 (0.6) |
1–999 | 147 (46.4) |
≥ 1000 | 168 (53.0) |
Plasma viral load after 12 months on ART, copies/ml (N = 411) | |
Median | 90 (20, 328) |
0 | 85 (20.7) |
1–999 | 283 (68.9) |
≥ 1000 | 43 (10.5) |